FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24520611000001109: Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79774901000001118 Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80121401000001116 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Is a Generic Dermovate-NN cream 30 gram true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has AMP Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has specific active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start